Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-14
2006-11-14
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S330000, C514S331000, C546S192000, C546S223000, C546S225000, C546S229000
Reexamination Certificate
active
07135483
ABSTRACT:
Substituted heterocyclinc compounds are disclosed. The compounds are useful for treating multidrug resistance. The compounds can be formulated in compositions with a carrier and, optionally, a therapeutic agent. One suitable substituted heterocyclic compound has the formula:
REFERENCES:
patent: 4029801 (1977-06-01), Cavalla et al.
patent: 4181722 (1980-01-01), Beranger et al.
patent: 4237139 (1980-12-01), Champseix et al.
patent: 4299835 (1981-11-01), Champseix et al.
patent: 4402961 (1983-09-01), Dubroeucq et al.
patent: 4433150 (1984-02-01), Champseix et al.
patent: 4442106 (1984-04-01), Trijzelaar et al.
patent: 4442107 (1984-04-01), Trijzelaar et al.
patent: 4443453 (1984-04-01), Trijzelaar et al.
patent: 4472403 (1984-09-01), Trijzelaar et al.
patent: 4505916 (1985-03-01), Champseix et al.
patent: 4584303 (1986-04-01), Huang et al.
patent: 4613607 (1986-09-01), Gueremy et al.
patent: 4791120 (1988-12-01), Lin et al.
patent: 4911928 (1990-03-01), Wallach
patent: 4916142 (1990-04-01), Bagley et al.
patent: 4923871 (1990-05-01), Inaba et al.
patent: 4935432 (1990-06-01), Matsuo et al.
patent: 4962115 (1990-10-01), Van Daele
patent: 4963553 (1990-10-01), Tseng et al.
patent: 4980351 (1990-12-01), Barth et al.
patent: 4985438 (1991-01-01), Archibald et al.
patent: 4985558 (1991-01-01), Suzuki et al.
patent: 4996321 (1991-02-01), Baldwin et al.
patent: 5013742 (1991-05-01), Kudzma et al.
patent: 5091187 (1992-02-01), Haynes
patent: 5098915 (1992-03-01), Dedsai et al.
patent: 5114919 (1992-05-01), Baldwin et al.
patent: 5124339 (1992-06-01), King
patent: 5130303 (1992-07-01), Akiyama et al.
patent: 5160727 (1992-11-01), Klohs et al.
patent: 5173486 (1992-12-01), Monkovic et al.
patent: 5177077 (1993-01-01), Hohlweg et al.
patent: 5182293 (1993-01-01), Sunkara et al.
patent: 5190946 (1993-03-01), Ramu et al.
patent: 5190957 (1993-03-01), Sunkara et al.
patent: 5204348 (1993-04-01), Fukazawa et al.
patent: 5216172 (1993-06-01), Toyota et al.
patent: 5225405 (1993-07-01), Paramelle et al.
patent: 5238936 (1993-08-01), Regnier et al.
patent: 5272159 (1993-12-01), Baldwin et al.
patent: 5292726 (1994-03-01), Ashton et al.
patent: 5292757 (1994-03-01), Ohsumi et al.
patent: 5302727 (1994-04-01), Eliason et al.
patent: 5336685 (1994-08-01), Prochaska et al.
patent: 5362729 (1994-11-01), Cozzi et al.
patent: 5371081 (1994-12-01), Houghton et al.
patent: 5389644 (1995-02-01), Peglion et al.
patent: 5409690 (1995-04-01), Howell et al.
patent: 5416091 (1995-05-01), King
patent: 5436243 (1995-07-01), Sachs et al.
patent: 5506239 (1996-04-01), Sato et al.
patent: 5508403 (1996-04-01), Akiyama et al.
patent: 5514664 (1996-05-01), Ulrich
patent: 5516775 (1996-05-01), Zimmermann et al.
patent: 5521184 (1996-05-01), Zimmermann
patent: 5523304 (1996-06-01), Sunkara
patent: 5525606 (1996-06-01), Moschel et al.
patent: 5536722 (1996-07-01), Coe et al.
patent: 5541232 (1996-07-01), Howell et al.
patent: 5543423 (1996-08-01), Zelle et al.
patent: 5543428 (1996-08-01), Sawyer et al.
patent: 5550149 (1996-08-01), Powell et al.
patent: 5569471 (1996-10-01), Oguro
patent: 5571687 (1996-11-01), Casey et al.
patent: 5583137 (1996-12-01), Coe et al.
patent: 5605896 (1997-02-01), Leonardi et al.
patent: 5610165 (1997-03-01), MacCoss et al.
patent: 5620971 (1997-04-01), Armistead et al.
patent: 5622953 (1997-04-01), Janssen et al.
patent: 5643869 (1997-07-01), Dreyfuss et al.
patent: 5654304 (1997-08-01), Pfister et al.
patent: 5663179 (1997-09-01), Dumaitre et al.
patent: 5665719 (1997-09-01), Bock et al.
patent: 5670508 (1997-09-01), Wang et al.
patent: 5670521 (1997-09-01), Freedman et al.
patent: 5693767 (1997-12-01), Klemke et al.
patent: 5698553 (1997-12-01), Pucher et al.
patent: 5700826 (1997-12-01), Mjalli et al.
patent: 5723459 (1998-03-01), Armistead et al.
patent: 5726184 (1998-03-01), Zelle
patent: 5733911 (1998-03-01), Eilon et al.
patent: 5736539 (1998-04-01), Graham et al.
patent: 5744485 (1998-04-01), Zelle et al.
patent: 5756422 (1998-05-01), Holdgrun et al.
patent: 5756475 (1998-05-01), Inomata et al.
patent: 5789402 (1998-08-01), Audia et al.
patent: 5814644 (1998-09-01), Kulagowski et al.
patent: 5830915 (1998-11-01), Pikul et al.
patent: 5834014 (1998-11-01), Weiner et al.
patent: 5840319 (1998-11-01), Alakhov et al.
patent: 5851789 (1998-12-01), Simon et al.
patent: 5928637 (1999-07-01), Gottesman et al.
patent: 5968956 (1999-10-01), Okada et al.
patent: 6174900 (2001-01-01), Okada et al.
patent: 6200990 (2001-03-01), Namil et al.
patent: 6211186 (2001-04-01), McIver et al.
patent: 6221872 (2001-04-01), Gangee
patent: 6258526 (2001-07-01), Stein et al.
patent: 6329377 (2001-12-01), Chatterjee
patent: 6376514 (2002-04-01), Degenhardt et al.
patent: 6403610 (2002-06-01), Malleron et al.
patent: 6413984 (2002-07-01), Philippo et al.
patent: 6448243 (2002-09-01), Kitazawa et al.
patent: 6476041 (2002-11-01), Thompson et al.
patent: 6498170 (2002-12-01), Sum et al.
patent: 6559146 (2003-05-01), Annoura et al.
patent: 6602884 (2003-08-01), Bacque et al.
patent: 6803362 (2004-10-01), Carruthers et al.
patent: 6806455 (2004-10-01), Zarare et al.
patent: 6809093 (2004-10-01), Degenhardt et al.
patent: 6815458 (2004-11-01), Andersson et al.
patent: 6815465 (2004-11-01), Makk et al.
patent: 2004/0132722 (2004-07-01), Degenhardt et al.
patent: 563610 (1958-06-01), None
patent: 3524955 (1986-01-01), None
patent: 19548797 (1997-07-01), None
patent: 0363212 (1990-11-01), None
patent: 2267104 (1975-11-01), None
patent: 2567885 (1985-07-01), None
patent: 2567885 (1986-01-01), None
patent: 2163150 (1986-02-01), None
patent: 09 12577 (1997-01-01), None
patent: WO 92/18478 (1992-10-01), None
patent: WO 92/18478 (1992-10-01), None
patent: WO 93/04042 (1993-03-01), None
patent: WO 94/07856 (1994-04-01), None
patent: WO 97/26240 (1997-07-01), None
patent: WO 99/65867 (1999-12-01), None
patent: WO 00/01714 (2000-01-01), None
patent: WO 00/18733 (2000-04-01), None
patent: WO 00/32588 (2000-06-01), None
patent: WO 00/37458 (2000-06-01), None
patent: WO 00/50418 (2000-08-01), None
patent: WO 01/58891 (2001-08-01), None
patent: WO 01/74769 (2001-10-01), None
Pajeva, I. et al, “A Comparative Molecular Field Analysis of Propafenone-typ Modulators of Cancer Multidrug Risistance”. Quant. Struct.—Act. Relat., 17. p. 301-312. (1998).
Roe, M. et al, “Reversal of P-Glycoprotein Mediated Multidrug Resistance by Novel Anthranilamide Derivatives”, Bioorganic & Medicinal Chemistry Letter, 9, p. 595-600, (1999).
Chiba, P. et al, “Synthesis, Pharmacologic Activity, and Structure—Activity Relationships of a Series of Propafenone-related modulators of Multidrug Resistance”, J. Med. Chemistry, 38, p. 2789-2793, (1995).
Ecker, G. et al, “Structure—Activity Relationship Studies of Benzofuran Analogs of Propafenone-type Modulators of Tumor Cell Multidrug Resistance”, Journal of Medicinal Chemistry, 39, p. 4767-4774 (1996).
Chiba, P. et al “Structural Requirements for Activity of Propafenone-type Modulators in P-Glycoprotein-Mediated Multidrug Resistance.” Molecular Pharmcology, 49, p. 1122-1130, (1996).
Chiba, P. et al “Synthesis and Pharmacologcal activity of the stereoisomers of GP-88, a Propafenone-type modulator of Multidrug resistance”, Bioorganic & Medicinal Chemistry Letter, 8, p. 829-832, (1998).
Chiba, P. et al, “Studies on Propafenone-type Modulators of Multidrug Resistance III: Variations on the Nitrogen”, Quant. Struct.-Act. Relat. 16, p. 361-366 (1997).
Chiba, P. et al “Studies on Propafenone-type Modulators of Multidrug-resistance IV: Synthesis and Pharmacological Activity of 5-Hydroxy and 5-Benzyloxy”, Arch. Pharm. Pharm. Med. Chem., 330, p. 343-347 (1997).
Oberlies, N. et al, “Structure—Activity Relationships of Diverse Annonaceous Acetogenins against Multidrug Resistant Human mammary Adenocarcinoma (MCF-7/Adr) Cells”, Journal of Medicinal Chemistry, 40, p. 2102-2106, (1997).
Conseil, G. et al, “Flavonoids: A class of modulators with bifunctional in
Degenhardt Charles Raymond
Eickhoff David Joseph
Desai Rita
H. Lee Moffitt Cancer Center & Research Institute, Inc.
Michael & Best & Friedrich LLP
LandOfFree
Substituted heterocyclic compounds for treating multidrug... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted heterocyclic compounds for treating multidrug..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heterocyclic compounds for treating multidrug... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3633097